State Of Wyoming Seagen Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $89,115 - $146,871	819 Added 25.81%	3,992 $706,000
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $58,728 - $77,504	491 Added 18.31%	3,173 $457,000
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $20,957 - $28,056	-147 Reduced 5.2%	2,682 $415,000
Q3 2021 Feb 11, 2022	SELL	$142.45 - $169.82 $202,563 - $241,484	-1,422 Reduced 33.45%	2,829 $480,000
Q2 2021 Feb 11, 2022	BUY	$135.08 - $161.1 $322,165 - $384,223	2,385 Added 127.81%	4,251 $671,000

Q1 2021 Feb 08, 2022	BUY	$137.51 - $190.8 $256,593 - $356,032	1,866 New	1,866 $259,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.